A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan

Authors:

Abstract
No abstract available
Funding Information
  • Natural Science Foundation of Beijing Municipality (M21013)
  • National Key Research and Development Program of China (2018YFA0900804)
  • National Natural Science Foundation of China (31970875, 82271869)

This publication has 45 references indexed in Scilit: